MYC and Ewing sarcoma: Treatment of the parental EW8 and TC71 cells, as well as additional Ewing sarcoma cell lines, with the RRM1 inhibitor gemcitabine also reduced the level of the c-Myc oncoprotein (Fig. 3F and G).